Blog Profile / Focus on Funds

Filed Under:Business & Finance / Investing
Posts on Regator:10941
Posts / Week:33
Archived Since:February 17, 2011

Blog Post Archive

All Banks Pass Dodd-Frank Stress Test

PNC, Wells Fargo, and M&T Bank reported the best DFAST results according to one analyst. What to expect when the Fed releases CCAR results next week.

2 ETFs Reacting Very Differently to New Home Sales Data

The iShares U.S. Home Construction ETF and the SPDR S&P Homebuilders ETF are not the same.

ETF Flyer: The Sun Shines on TAN

Fans of renewable energy abound, including none other than President Trump.

JNUG Jumps as Gold Glitters Again

Small-cap gold miners-tracking exchange-traded funds are gaining big.

Natural Gas: the Price is Right

Natural gas prices look attractive at $2.90/mmbtu, says one RBC Capital Markets analyst.

Is Trump Responsible for TAN’s Breakout?

The Guggenheim Solar ETF hit a fresh seven-month high, clearing its 200-day moving average.

Oil Prices are Getting a Lift, Time to Worry About Cocoa?

Falling cocoa prices may be "anchoring" bond yields and the U.S. dollar, according to Societe Generale.

ETF Flopper: Everything Oil Touches Gets a Black Mark

Energy stocks got hit. Oil equipment and services companies bore the brunt of it.

ETF Flyer: Biotech Stocks Climb for 3 Straight Days

The SPDR S&P Biotech ETF was among the best-performing on Wednesday.

Draft EO on Drug Prices Looks Benign; Can Biotech Keep Rippin’ Up?

One technical analyst says iShares Nadsdaq Biotechnology looks stronger than it did in prior breakouts.

Yes, There is Another Way to Play BDCs

This closed-end fund looks like a pretty good substitute for the 'world's most expensive ETF.'

Oil: Bear-ish? We’ll Show You Bearish

One investment bank just downgraded 51 energy-related companies on a lower long-term crude oil forecast.

Time to Sell Europe Stocks?

Deutsche Bank's equity strategist expects Europe stocks to lag behind U.S. stocks.

ETF Flopper: European Bank Stocks Feel the Burn

European bank stocks were burned following the first round of Brexit negotiations.

Biotech ETFs: Still Riding High

The biotechnology-stock rally continues. The SPDR S&P Biotech (XBI) and the iShares Nasdaq Biotechnology (IBB), among the highest-flying exchange-traded funds yesterday, both hit their 52-week highs on Tuesday. Photo by Peter Macdiarmid/Getty Images The SPDR S&P has gained 2.7% while the iShares Nasdaq has climbed 2.3% so far. Show More Summary

Crude Oil: Enter the Bear?

Crude oil prices are off more than 20% from its February peak.

After the Tech Wreck: XLK vs VGT

The two largest technology-stock tracking ETFs are being treated very differently. And why one technical strategist says investors should wait before putting more money in tech.

Copyright © 2015 Regator, LLC